Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Mueller

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Nature Structural & Molecular Biology|July 1, 2024
Early intermediates in bacterial RNA polymerase promoter melting visualized by time-resolved cryo-electron microscopyRuth M Saecker, Andreas U Mueller, Brandon Malone, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Early intermediates in bacterial RNA polymerase promoter melting visualized by time-resolved cryo-electron microscopyRuth M Saecker, Andreas U Mueller, Brandon Malone, et al.
Blood|January 27, 2012
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortJanet L Kwiatkowski, Hae-Young Kim, Alexis A Thompson, et al.
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Pediatrics|December 1, 2021
Preventing Home Medication Administration ErrorsH Shonna Yin, Daniel R Neuspiel, Ian M Paul, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Nature Structural & Molecular Biology|July 1, 2024
Early intermediates in bacterial RNA polymerase promoter melting visualized by time-resolved cryo-electron microscopyRuth M Saecker, Andreas U Mueller, Brandon Malone, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Early intermediates in bacterial RNA polymerase promoter melting visualized by time-resolved cryo-electron microscopyRuth M Saecker, Andreas U Mueller, Brandon Malone, et al.
Blood|January 27, 2012
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortJanet L Kwiatkowski, Hae-Young Kim, Alexis A Thompson, et al.
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Pediatrics|December 1, 2021
Preventing Home Medication Administration ErrorsH Shonna Yin, Daniel R Neuspiel, Ian M Paul, et al.
Pageof 22